vimarsana.com

Page 24 - ஆலிஸ் வாலன்பெர்க் அடித்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SAS CEO leaves airline after 10 years at the helm

New promising antibodies against SARS-CoV-2

 E-Mail IMAGE: Cell culture plates with stained cells, in which virus replication can be quantified by the ‚holes that virus infection causes in the cell lawn. view more  Credit: © Volker Lannert/ University of Bonn Antibodies are an important weapon in the immune system s defense against infections. They bind to the surface structures of bacteria or viruses and prevent their replication. One strategy in the fight against disease is therefore to produce effective antibodies in large quantities and inject them into the patients. The outgoing US President Donald Trump probably owes his rapid recovery to this method. However, the antibodies used to treat him have a complex structure, do not penetrate very deeply into the tissue and may cause unwanted complications. Moreover, producing antibodies is difficult and time-consuming. They are therefore probably not suitable for widespread use.

New small antibodies show promising effects against COVID-19 infection

Formula predicts ideal dose of stem cells to cure HIV

 E-Mail Scientists have determined the optimal conditions following a stem cell transplant that could control HIV without the need of an everyday pill, according to a study published today in eLife. Finding the right balance of stem cell dose, cell type and timing of antiretroviral therapy (ART) could potentially lead to a spontaneous cure of HIV. There are only two cases of HIV cure to date: the Berlin Patient and the London Patient, who both received stem cell transplants with stem cells from donors that lack a molecule called CCR5, which HIV is attracted to. The major obstacle to HIV eradication is a latent reservoir of long-lived infected cells, and cure strategies aim to eliminate all infected cells or permanently prevent viral reactivation from latency, explains first author E. Fabian Cardozo-Ojeda, Senior Staff Scientist at the Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, US. We wanted to recreate the cures seen in the Ber

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.